4.7 Article

MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase γ pathway

Journal

RHEUMATOLOGY
Volume 57, Issue 4, Pages 718-726

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kex451

Keywords

familial Mediterranean fever; miR-204-3p; PIK3CG; interleukin-6

Categories

Funding

  1. Japan Agency for Medical Research and Development [15657398]
  2. Grants-in-Aid for Scientific Research [26461481, 16K19605, 17H04656, 17K09981, 15K09531] Funding Source: KAKEN

Ask authors/readers for more resources

Objective. We sought to identify the microRNA (miRNA) profile and potential biomarkers in FMF and to clarify their gene targets to elucidate the pathogenesis of FMF. Methods. We performed an miRNA microarray using serum from FMF patients in attack and in remission. We then examined the expression of miRNAs in macrophages derived from THP-1 cells stimulated with toll-like receptor (TLR) ligands. Macrophages derived from THP-1 cells transfected with pre-miRNA were stimulated with lipopolysaccharides (LPSs) for the quantification of inflammatory cytokine production. To identify the target genes, we overexpressed their miRNA and performed a complementary DNA microarray. Transfection with reporter construct and the precursor miRNA was performed to confirm the suppression of target mRNA. Results. We found that miR-204-3p was greatly decreased in the serum from FMF patients in attack. The expression of miR-204-3p was suppressed by LPS stimulation in the macrophages derived from THP-1 cells and the inhibition of miR-204-3p significantly induced the production of TLR4-related cytokines. The bioinformatic analysis showed that miR-204-3p is predicted to target genes implicated in the TLR pathway through the regulation of PI3K gamma signalling. The reporter assay revealed that miR-204-3p directly suppressed the luciferase activity of 3'-UTR of PIK3CG reporter construct. The inhibition of PI3K gamma resulted in decreased amounts of IL-6 and IL-12p40 in monocytes from FMF patients. Conclusion. These data suggest that serum miR-204-3p has potential as a useful biomarker in FMF patients and that miR-204-3p serves as a suppressor of inflammatory cytokine production in FMF by targeting the PI3K gamma pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan

Y. Endo, S-Y Kawashiri, A. Nishino, T. Michitsuji, T. Tomokawa, S. Nishihata, M. Okamoto, Y. Tsuji, S. Tsuji, T. Shimizu, R. Sumiyoshi, T. Igawa, T. Koga, N. Iwamoto, K. Ichinose, M. Tamai, H. Nakamura, T. Origuchi, Y. Ueki, T. Yoshitama, N. Eiraku, N. Matsuoka, A. Okada, K. Fujikawa, H. Otsubo, H. Takaoka, H. Hamada, T. Tsuru, M. Nawata, Y. Arinobu, T. Hidaka, Y. Tada, A. Kawakami

Summary: The study investigated the effectiveness of treatment with JAK inhibitors in rheumatoid arthritis patients, assessed by ultrasonography activity, and the impact of patient characteristics and previous treatments. The results showed that JAK inhibitors in combination with methotrexate and an absence of inadequate response to previous treatments demonstrated superior effectiveness for patients with RA, as indicated by improvement in clinical disease activity and US activity at 6 months compared with baseline.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2022)

Article Immunology

Tissue resident cell processes determine organ damage in systemic lupus erythematosus

Tomohiro Koga, Kunihiro Ichinose, George C. Tsokos

Summary: Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs. Immune abnormalities contribute to the expression of the disease, with elements of the immune system instigating cellular damage. Correcting immune aberrations and preventing organ damage are both important.

CLINICAL IMMUNOLOGY (2022)

Article Medicine, General & Internal

Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab

Kazusato Hara, Masataka Umeda, Keiko Segawa, Midori Akagi, Yushiro Endo, Tomohiro Koga, Shin-Ya Kawashiri, Kunihiro Ichinose, Hideki Nakamura, Takahiro Maeda, Atsushi Kawakami

Summary: This article reports a case of a Japanese male patient with giant cell arteritis and atypical Cogan's syndrome. The patient achieved significant improvement after receiving tocilizumab treatment following an inadequate response to oral prednisolone.

INTERNAL MEDICINE (2022)

Article Medicine, General & Internal

Severe Anemia Due to Cold Agglutinin Syndrome in a COVID-19 Patient with IgM Monoclonal Gammopathy of Undetermined Significance Successfully Treated with Corticosteroids

Yutaka Tsukamoto, Masataka Umeda, Yuko Muto, Takashi Sugimoto, Momoko Yamauchi, Koji Ando, Koya Ariyoshi

Summary: This case report describes the first Asian case of secondary cold agglutinin syndrome (CAS) secondary to COVID-19. The patient also had monoclonal gammopathy of undetermined significance (MGUS). Corticosteroid therapy was effective in treating the anemia, suggesting its potential efficacy in CAS secondary to COVID-19 complicated with MGUS.

INTERNAL MEDICINE (2022)

Article Rheumatology

Role of Glutaminase 2 in Promoting CD4+T Cell Production of Interleukin-2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus

Ryo Hisada, Nobuya Yoshida, Seo Yeon K. Orite, Masataka Umeda, Catalina Burbano, Marc Scherlinger, Michihito Kono, Suzanne Krishfield, George C. Tsokos

Summary: The study revealed the crucial role of GLS2 in IL-2 production by CD4+ T cells, as well as its involvement in supporting antioxidant defense. These findings offer a new approach to correcting IL-2 production by T cells in SLE.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Immunology

Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia

Yuya Fujita, Shoichi Fukui, Masataka Umeda, Sosuke Tsuji, Naoki Iwamoto, Yoshikazu Nakashima, Yoshiro Horai, Takahisa Suzuki, Akitomo Okada, Toshiyuki Aramaki, Yukitaka Ueki, Akinari Mizokami, Tomoki Origuchi, Hiroshi Watanabe, Kiyoshi Migita, Atsushi Kawakami

Summary: Patients with hypocomplementemia in IgG4-related disease (IgG4-RD) exhibit a more active clinical phenotype, suggesting the involvement of the complement system in the pathophysiology of IgG4-RD.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study

Shunsuke Mori, Akitomo Okada, Tomohiro Koga, Yukitaka Ueki

Summary: Discontinuation of bDMARDs/tofacitinib may be a feasible strategy in patients with rheumatoid arthritis, especially those with early treated and longer-controlled RA. Flares are manageable in most patients and radiological progression is rare for at least 3 years after discontinuation of bDMARDs/tofacitinib.

PLOS ONE (2022)

Article Biochemistry & Molecular Biology

Generation of antagonistic monoclonal antibodies against the neoepitope of active mouse interleukin (IL)-18 cleaved by inflammatory caspases

Yuki Uchida, Yuko Nariai, Eiji Obayashi, Yoshitsugu Tajima, Tomohiro Koga, Atsushi Kawakami, Takeshi Urano, Hiroki Kamino

Summary: In this study, novel anti-mouse IL-18 neoepitope antibodies were generated and a method to evaluate the activity of mouse IL-18 was established. The therapeutic efficacy of the anti-mouse IL-18 neoepitope antibodies was demonstrated in mouse models, providing proof-of-concept for their potential application in human inflammatory diseases.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2022)

Article Medicine, General & Internal

The Toll-like Receptor 7-Mediated Ro52 Antigen-Presenting Pathway in the Salivary Gland Epithelial Cells of Sjogren's Syndrome

Shin-Ya Nishihata, Toshimasa Shimizu, Masataka Umeda, Kaori Furukawa, Kaname Ohyama, Atsushi Kawakami, Hideki Nakamura

Summary: This study aimed to investigate the effect of toll-like receptor (TLR) 7 stimulation on the antigen presentation of tripartite motif-containing protein 21 (TRIM21) or Ro52/SS-A through major histocompatibility complex (MHC) class I in salivary gland epithelial cells (SGECs) from patients with Sjogren's syndrome (SS). SGECs from SS patients were stimulated with TLR7 agonist loxoribine and interferon-β. Increased MHC class I expression and enhanced Ro52 expression were observed in TLR7-stimulated SGECs, indicating the advancement of antigen presentation in SS patients' SGECs.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Rheumatology

Intravenous cyclophosphamide treatment for systemic lupus erythematosus with severe autonomic disorders confirmed by head-up tilt table test: A case series

Masataka Umeda, Hiroaki Kawano, Yushiro Endo, Ayuko Takatani, Tomohiro Koga, Kunihiro Ichinose, Hideki Nakamura, Akihiro Mukaino, Osamu Higuchi, Shunya Nakane, Takahiro Maeda, Atsushi Kawakami

Summary: This article describes three cases of severe autonomic disorders in systemic lupus erythematosus (SLE) patients, as demonstrated by the head-up tilt table test (HUT). These patients were treated with intensive immunosuppressive therapy, which resulted in negative HUT results, suggesting that this treatment may be effective for severe autonomic disorders in SLE patients. HUT is a useful objective method for diagnosing and evaluating the therapeutic effects of autonomic disorders in SLE patients with orthostatic intolerance.

MODERN RHEUMATOLOGY CASE REPORTS (2022)

Article Immunology

Comparison of complications during 1-year follow-up between remitting seronegative symmetrical synovitis with pitting edema syndrome and elderly-onset rheumatoid arthritis

Tomoki Origuchi, Masataka Umeda, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Toshiaki Tsukada, Taiichiro Miyashita, Nozomi Iwanaga, Yoshiro Horai, Kazuhiko Arima, Toshiyuki Aramaki, Yukitaka Ueki, Katsumi Eguchi, Atsushi Kawakami

Summary: This study compared the complications during a 1-year follow-up in corticosteroid-treated RS3PE patients and EORA patients. While there was no significant increase in cardiovascular diseases, infections were significantly higher in RS3PE patients, with the initial corticosteroid dose being a risk factor for infections.

IMMUNOLOGICAL MEDICINE (2022)

No Data Available